XML 37 R27.htm IDEA: XBRL DOCUMENT v3.22.4
Capital Stock and Equity Transactions (Details Narrative) - USD ($)
6 Months Ended 12 Months Ended
Oct. 13, 2021
Dec. 31, 2022
Dec. 31, 2021
Sep. 30, 2020
Jun. 30, 2022
Common stock, shares authorized (in shares)   700,000,000 700,000,000   700,000,000
Common stock, par value (in dollars per share)   $ 0.001 $ 0.001   $ 0.001
Preferred stock, shares authorized (in shares)     10,000,000    
Derivative liability $ 4,392,870        
Increase in common shares $ 150,000,000     $ 838,303  
Common stock on a fully diluted basis   $ 98,772     $ 93,315
Common stock shares issued   95,030,830     93,316,288
Vendor [Member]          
Fair market value of shares issued and expensed   $ 28,500 $ 814,790    
Issuance of common stock to vendors   600,000 57,541    
Employees [Member]          
Common stock shares issued   1,114,542 1,397,135    
Fair market value   $ 50,455 $ 118,760    
Preferred Stock Series A [Member]          
Preferred stock, shares authorized (in shares)   10,000,000     10,000,000
Preferred stock, par value (in dollars per share) $ 0.001 $ 0.001     $ 0.001
Aggeregate shares of common stock 324,325        
Common stock on a fully diluted basis     $ 3,714,877    
Series B Preferred Stock [Member]          
Aggeregate shares of common stock   7,567      
Common stock shares issued upon conversion of preferred stock   1,120,064